These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26384162)

  • 1. Insights into the strong in-vitro anticancer effects for bis(triphenylphosphane)iminium compounds having perchlorate, tetrafluoridoborate and bis(chlorido)argentate anions.
    Folda A; Scalcon V; Ghazzali M; Jaafar MH; Khan RA; Casini A; Citta A; Bindoli A; Rigobello MP; Al-Farhan K; Alsalme A; Reedijk J
    J Inorg Biochem; 2015 Dec; 153():346-354. PubMed ID: 26384162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase.
    Yan K; Lok CN; Bierla K; Che CM
    Chem Commun (Camb); 2010 Nov; 46(41):7691-3. PubMed ID: 20623063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
    Cheng Y; Qi Y
    Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells.
    Engman L; Kandra T; Gallegos A; Williams R; Powis G
    Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
    Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
    Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
    Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
    J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
    Casini A; Gabbiani C; Sorrentino F; Rigobello MP; Bindoli A; Geldbach TJ; Marrone A; Re N; Hartinger CG; Dyson PJ; Messori L
    J Med Chem; 2008 Nov; 51(21):6773-81. PubMed ID: 18834187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
    Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
    Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.
    He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H
    Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion.
    Warżajtis B; Glišić BĐ; Savić ND; Pavic A; Vojnovic S; Veselinović A; Nikodinovic-Runic J; Rychlewska U; Djuran MI
    Dalton Trans; 2017 Feb; 46(8):2594-2608. PubMed ID: 28155927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies.
    Fabbrini MG; Cirri D; Pratesi A; Ciofi L; Marzo T; Guerri A; Nistri S; Dell'Accio A; Gamberi T; Severi M; Bencini A; Messori L
    ChemMedChem; 2019 Jan; 14(1):182-188. PubMed ID: 30444581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
    Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
    Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
    Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.
    Pettinari C; Marchetti F; Lupidi G; Quassinti L; Bramucci M; Petrelli D; Vitali LA; da Silva MF; Martins LM; Smoleński P; Pombeiro AJ
    Inorg Chem; 2011 Nov; 50(21):11173-83. PubMed ID: 21999582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
    Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
    Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
    McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
    J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.